Abstract:Essential hypertension represents a multifactorial set of genetic dysfunctions that involve several organ systems, including the kidney. The mechanistic underpinnings of hypertension has been facilitated by the availability of knockout mouse models, which allow the functional analysis of specific genes involved in the regulation of blood pressure (BP) and ion transport. Recent innovations on knockout mouse models, e.g., conditional knockouts, allow the reversible silencing of genes in a limited number of tissues; however, this technology is tedious, expensive and not always successful. Moreover, the use of gene complementation techniques has been instrumental in confirming the function of genes of interest in vivo . Therefore, we evaluated the feasibility and efficiency of using two complementary techniques to study gene function in mice, namely, the (1) delivery of gene‐specific siRNA via an osmotic pump into the renal parenchyma, and (2) bolus retrograde injection of the gene of interest packaged in AAV9 viral vectors into the ureter of the kidney. Previously uninephrectomized and acclimated mice were surgically implanted with an osmotic pump equipped with an attached 28G‐tipped polyurethane tube to infuse siRNA dissolved in an in vivo transfection reagent into the subcapsular space of the kidney. A 28‐day siRNA infusion (3μg/day) which ensured optimum silencing of the targeted gene neither resulted in gross or histological changes in the renal morphology nor spillage into other organ systems, i.e. the heart and liver. We silenced the renal Drd2 gene expression by ~65% in four C57Bl/6J mice which resulted in increased systolic blood pressure (DSBP=21±4.5 mm Hg vs . 1.0±2.9 mm Hg, measured via the femoral artery, in non‐silencing “mock” siRNA‐treated mice), similar to the hypertension observed in Drd2 knockout mice; Drd2 encodes for the dopamine receptor type 2, D 2 R, whose absence results in hypertension. When a siRNA against a gene (e.g., USP48 which prevents the degradation of NHE3) whose absence should decrease BP was tested, systolic BP was effectively decreased (DSBP=−21±2 mm Hg; n=5), suggesting that the resultant phenotype depends upon the specific gene being silenced. We next compared the effect of unilateral infusion of Drd2 ‐specific siRNA in mice with both kidneys intact. The BP was unchanged after a 7‐day infusion, but increased after 28 days of infusion (DSBP=26±2 mm Hg; n=5), suggesting that the presence of the contralateral, non‐infused kidney could initially compensate for the loss of D 2 R but not in the long‐term. The unilateral renal infusion of siRNA did not change the D 2 R expression of the non‐infused kidney, regardless of the duration of infusion, demonstrating the feasibility to use one kidney as an internal control for the functional analysis of gene silencing in the targeted kidney. We next performed gene rescue experiments in C57Bl/6J mice that have been previously depleted of their renal D 2 R using a human Drd2 gene subcloned in a mammalian expression vector and packaged in an AAV9 viral vector. Fifteen days post‐silencing, a bolus of Drd2 ‐AAV9 was given via retrograde ureteral injection. The D 2 R expression increased 7.5‐fold (compared to control) and the blood pressure was normalized at 14 days post‐infusion; mock‐AAV9 had no effect n=3/group). Our novel strategies for gene silencing and gene rescue in mice may prove to be an easier and more versatile approach of genetic manipulation compared to traditional methods. Support or Funding Information The work was funded by grants from the US National Institutes of Health: P01HL074940, P01HL068686, R01HL092196, R37HL023081, R01DK039308, and DK090918.

GENETIC DELETION OR PHARMACOLOGICAL INHIBITION OF THE SODIUM AND HYDROGEN EXCHANGER 3 IN THE PROXIMAL TUBULES OF THE KIDNEY ATTENUATES ANGIOTENSIN II AND SALT-INDUCED HYPERTENSION

New Insights into the Critical Importance of Intratubular Na+/H+ Exchanger 3 and Its Potential Therapeutic Implications in Hypertension

Angiotensin II and AT1a Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and Hypertension

Deletion of AT1a receptors selectively in the proximal tubules alters the hypotensive and natriuretic response to ANP via NPRA/cGMP/NO Signaling

MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.

A low salt diet increases blood pressure in mice with selective deletion of the dopamine D2 receptor in the renal proximal tubule

Signaling crosstalk between Dipeptidyl Peptidase 4 and Angiotensin II-AT1R plays a role in proximal tubule NHE3 regulation and salt sensitive hypertension

Abstract 45: Deletion of a 4-Bp Noncoding Genomic Segment Orthologous to Human Rs1882961 Results in Sex-Divergent Changes in Salt-Induced Hypertension in Dahl Salt-Sensitive Rats

Abstract 050: mir-192-5p in the Kidney is Protective Against the Development of Hypertension

Abstract 070: Deletion of A Non-coding Genomic Segment Orthologous to the Human Rs1173771 Haplotype Region Attenuates Hypertension in Dahl Salt-sensitive Rats

Impact of Proximal Tubule-Specific Deletion of Dipeptidyl Peptidase 4 on Blood Pressure, Renal Sodium Handling, and NHE3 Phosphorylation

Vascular control of kidney epithelial transporters

Inhibition of Nitric Oxide Synthase 1 Induces Salt-Sensitive Hypertension in Nitric Oxide Synthase 1α Knockout and Wild-Type Mice

IMPACT OF NLRP3 INFLAMMASOME ON THE DEVELOPMENT OF HYPERTENSION AND RENAL AND CARDIAC HYPERTROPHY IN 2K1C AND DOCA/SALT MICE

Abstract 065: Overexpression of an Intracellular Angiotensin II Fusion Protein Selectively in the Mitochondria of the Proximal Tubules Elevates Blood Pressure in Mice Via AT 1a Receptor-mediated Mitochondrial Respiratory and Glycolysis Stress

Role of Anterior Hypothalamic Angiotensin II in the Pathogenesis of Salt Sensitive Hypertension in the Spontaneously Hypertensive Rat.

Genetic Deletion of β-Arrestin 2 From the Subfornical Organ and Other Periventricular Nuclei in the Brain Alters Fluid Homeostasis and Blood Pressure

Abstract P236: Site-1 Protease-derived Soluble (pro) Renin Receptor Mediates Angiotensin II-induced Hypertension Via Activation of Intrarenal Renin System

Abstract 031: Mutagenesis of the Cleavage Site of (pro)renin Receptor Abrogates Aldosterone-salt-induced Hypertension and Renal Injury in Mice

Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II–Induced Hypertension

Novel Approaches to Manipulate Gene Expression in the Mouse Kidney: siRNA Silencing and Gene Rescue